Yesterday, inspired by a post by fellow ScienceBlogger Martin, I had a little fun discussing the evolution of “alternative” medicine (a.k.a. “complementary and alternative medicine” or CAM), specifically speculating about the possible selective pressures, positive and negative, that have influenced the course that its evolution took. Essentially, the discussion centered around whether, by its very […]
Category: Medicine
Abel Pharmboy at Terra Sigillata has the full story. In brief, Medicare has slashed reimbursement for two radioimmunotherapy drugs Bexxar (131I-tositumomab) and Zevalin (90Y-ibritumomab) to below acquisition cost. This is not some experimental therapy that’s being denied, but rather a therapy with a established clinical efficacy. Naturally, this is likely to lead to most centers […]
Share this:
I wish I had thought of this one, but I didn’t. However, I never let a little thing like not having thought of an idea first to stop me from discussing it, and this particular idea is definitely worth expanding upon because (1) it’s interesting and (2) it combines two of my interests, alternative medicine […]
Share this:
Orac gets e-mail from time to time. This time around, a person working at The Ohio State University writes about a disturbing incident there demonstrating yet more evidence that academic medical centers are having increasing difficulty distinguishing between evidence-based medicine (which they should champion) and non-evidence-based medicine, which they should not. This e-mail comes from […]
Share this:
Now this is unexpected. Normally, I find my victims/targets/subjects for my usual end-of-the-workweek bit of fun and skepticism from one of two sources. Either a reader sends a link to some woo or other that desperately deserves a little bit of Orac’s loving attention, or in my wanderings across blogosphere I find some little (or […]
